You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

AstraZeneca kidney inflammation treatment trial reaches dosing stage

Following its phase 2 proof of concept trial, Saphnelo – also know as anifrolumab – has been provided to patients as part of the critical IRIS phase 3 clinical trial to treat lupus nephritis (LN).